CARDIOCOMM : LAUNCHES NEW GEMS™ MOBILE UNIVERSAL ECG APP EXPANDING ECG REPORTING SERVICES ACROSS GLOBAL MARKETS
March 25, 2019 at 09:10 am EDT
Share
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ('CardioComm' or the 'Company'), a leading global medical provider of consumer heart monitoring and electrocardiogram ('ECG') acquisition and management software solutions, announces the release of a new version of the Company's recently cleared US Food and Drug Administration ('FDA') GEMS™ Mobile ECG app. The new version is branded as the GEMS™ Universal ECG ('GEMS™ Universal') and is capable of connecting with multiple manufacturer's consumer and prescription ECG devices sold globally.
The GEMS™ Universal ECG app allows users access to CardioComm's fee-for-use SMART Monitoring ECG reading service, through which they can request a review of their ECG(s) to confirm the presence or absence of arrhythmias. GEMS™ Universal will be available for a fee of $6 per month, which will include one free ECG triage. GEMS Universal will also be available under an annual fee of $69, with 12 free triage reports included. These reports may be requested at any time during a renewable one year subscription. CardioComm device partners will share in revenues generated from downloads of the app and from SMART Monitoring ECG readings.
GEMS™ Universal is a slimmed-down version of the Company's Health Canada-approved, FDA-cleared and CE Mark-certified, hospital-based Global ECG Management System (GEMSTM). GEMS™ Universal will be marketed for use with non-HeartCheck™ branded ECG devices, and will allow users the ability to generate unlimited, medical-grade ECG PDFs in near-real-time.
The first release of the GEMS™ Universal ECG is compatible with several OEM and private label devices, including those manufactured by Contec Medical Systems and BORSAM Biomedical Instruments. These manufacturers provide CardioComm with access to a global audience of ECG device users in regions where other companies have already established hardware sales.
The GEMS™ ECG Universal ECG app is scheduled to be available on the App Store and Google Play in April.
For further updates regarding GEMSTM Mobile ECG device partnerships please see the Company's websites at www.cardiocommsolutions.com and www.theheartcheck.com.
Attachments
Original document
Permalink
Disclaimer
CardioComm Solutions Inc. published this content on 25 March 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 25 March 2019 13:09:04 UTC
CardioComm Solutions, Inc. is a Canada-based company, which develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company's specialization is in the software engineering of computer based (ECG) management and reporting software. The software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings. The Companyâs device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for the recording, transmission, viewing, analyzing, reporting and storage of electrocardiograms, for arrhythmia screening, diagnosis, and management of cardiac patients. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians.
CARDIOCOMM SOLUTIONS, INC. 
